Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Heidelberg Bayer |
---|---|
Information provided by: | University of Heidelberg |
ClinicalTrials.gov Identifier: | NCT00447304 |
Acute cholecystitis is frequent in the elderly, or in patients with gall stones. Most cases of severe or recurrent cholecystitis need surgery as final therapy. Today, the performed procedure in most cases for cholecystectomy in the western world is laparoscopic cholecystectomy. Only in some cases an open surgery has to be performed. Unclear is, what time point is best, concerning outcome and morbidity of the patient, immediate surgery or initial conservative therapy using antibiotics and symptomatic therapy with cholecystectomy later on. Today the performed procedure is mainly chosen by the fact, what doctor sees the patient first, surgeon or gastroenterologist. This study is performed to evaluate if one therapy is superior.
Condition | Intervention | Phase |
---|---|---|
Acute Cholecystitis |
Drug: moxifloxacin Procedure: cholecystectomy |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Acute Cholecystitis – Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy = ACDC-Study |
Estimated Enrollment: | 644 |
Study Start Date: | October 2006 |
Estimated Study Completion Date: | March 2007 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Patients with acute cholecystitis based on three of the following signs
Exclusion Criteria:
Contact: Markus W Buechler, Prof. | 6221-566200 ext +49 | markus.buechler@med.uni-heidelberg.de |
Contact: Jens Encke, Prof. | 06221-568825 ext +49 | jens.encke@med.uni-heidelberg.de |
Germany | |
University Hospital Heidelberg | Recruiting |
Heidelberg, Germany, 69120 | |
Contact: Jens Encke, Prof 6221-568825 ext +49 jens.encke@med.uni-heidelberg.de | |
Contact: Carsten Gutt, Prof. 6221-5636334 ext +49 carsten.gutt@med.uni-heidelberg.de | |
Principal Investigator: Jens Encke, Prof. | |
Principal Investigator: Carsten Gutt, Prof. | |
Sub-Investigator: Joerg Koeninger, PD Dr. | |
Sub-Investigator: Kilian Weigand, Dr. |
Study Director: | Markus W Buechler, Prof. | University Hospital Heidelberg, Department of Surgery, Heidelberg, Germany |
Study Director: | Wolfgang Stremmel, Prof | University Hospital Heidelberg, Department of Gastroenterology, Heidelberg, Germany |
Study ID Numbers: | 2006-002056-14, AC-DC-01/Version 02/6.04.06 |
Study First Received: | March 13, 2007 |
Last Updated: | March 13, 2007 |
ClinicalTrials.gov Identifier: | NCT00447304 |
Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
acute cholecystitis cholecystectomy antibiotic treatment |
moxifloxacin intraabdominal infection morbidity and mortality of patients with acute cholecystitis, early surgery versus conservative therapy |
Gallbladder Diseases Digestive System Diseases Moxifloxacin Cholecystitis, Acute |
Acalculous Cholecystitis Biliary Tract Diseases Cholecystitis |
Anti-Infective Agents Therapeutic Uses Pharmacologic Actions |